Syneron Bio

Next-generation macrocyclic peptide therapeutics powered by the Synova™ platform

Beijing, United States · Founded 2022 · $250.0M raised

Headquarters
Beijing
Employees
51–200
Founded
2022
Business Model
B2B
Total Funding
$250.0M
Last Round
$150.0M Venture RoundApr 2026
Rounds
2

About

Syneron Bio is a Beijing-based biotech company dedicated to the development of next-generation macrocyclic peptide therapeutics, leveraging artificial intelligence and drug synthesis technology. The company has completed Series A, A+, and Series B financing rounds totaling approximately $400M, with backers including AstraZeneca. It operates in the intersection of AI and synthetic biology for drug discovery.

Summary

Syneron Bio is a Biotech company based in Beijing, United States, founded in 2022. It has raised $250.0M in total across 2 rounds, most recently a $150.0M Venture Round round in Apr 2026. Investors include ARCH Venture Partners, Lilly Asia Ventures and Tencent.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Venture RoundVenture RoundApr 2026
$150.0M

Sign up to see all 2 rounds

Series A through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Syneron Bio on Indexed.vc
<a href="https://indexed.vc/companies/syneron-bio"><img src="https://indexed.vc/api/badge/company/syneron-bio" alt="Syneron Bio on Indexed.vc" width="260" height="76" /></a>